Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
30.91B
Market cap30.91B
Price-Earnings ratio
12.31
Price-Earnings ratio12.31
Dividend yield
2.79%
Dividend yield2.79%
Average volume
4.28M
Average volume4.28M
High today
$74.84
High today$74.84
Low today
$73.00
Low today$73.00
Open price
$73.11
Open price$73.11
Volume
2.89M
Volume2.89M
52 Week high
$148.30
52 Week high$148.30
52 Week low
$68.77
52 Week low$68.77

Stock Snapshot

With a market cap of 30.91B, Zoetis(ZTS) trades at $74.79. The stock has a price-to-earnings ratio of 12.31 and currently yields dividends of 2.79%.

During the trading session on 2026-10-11, Zoetis(ZTS) shares reached a daily high of $74.84 and a low of $73.00. At a current price of $74.79, the stock is +2.5% higher than the low and still -0.1% under the high.

Trading volume for Zoetis(ZTS) stock has reached 2.89M, versus its average volume of 4.28M.

The stock's 52-week range extends from a low of $68.77 to a high of $148.30.

The stock's 52-week range extends from a low of $68.77 to a high of $148.30.

ZTS News

MarketWatch 2d
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
The Motley Fool 2d
A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now

Though the S&P 500 remains near an all-time high, many steady-Eddie dividend stocks have not gone along for the ride. In fact, many of these top-tier dividend g...

A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now
Simply Wall St 3d
Zoetis Gets A Fresh Heartworm Boost While Fair Value Stays In Focus

Advertisement Why Zoetis is back on investors’ radar Fresh peer reviewed data on Simparica Trio has put Zoetis (ZTS) in focus, showing stronger protection aga...

Zoetis Gets A Fresh Heartworm Boost While Fair Value Stays In Focus

Analyst ratings

58%

of 19 ratings
Buy
42.1%
Hold
57.9%
Sell
0%

More ZTS News

TipRanks 3d
Zoetis Declares Fourth-Quarter Dividend, Signals Ongoing Strength

Zoetis ( (ZTS) ) has issued an update. On October 8, 2026, Zoetis Inc., the global leader in animal health solutions, declared a fourth-quarter 2026 dividend o...

TipRanks 3d
Zoetis put volume heavy and directionally bearish

Bearish flow noted in Zoetis (ZTS) with 2,293 puts trading, or 1.3x expected. Most active are Mar-27 50 puts and Mar-27 65 puts, with total volume in those stri...

Simply Wall St 4d
Heartworm Study Results Change The Bull Case For Zoetis Stock?

Zoetis recently reported peer reviewed data in Parasites & Vectors showing Simparica Trio achieved 99.5% efficacy against a macrocyclic lactone resistant heartw...

Heartworm Study Results Change The Bull Case For Zoetis Stock?
TipRanks 5d
Zoetis announces peer-review publication on Simparica Trio

New peer-reviewed findings published in the journal Parasites & Vectors show that Zoetis (ZTS)’ Simparica Trio protected more dogs from adult heartworm infectio...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.